Tesla
TSLA
Amazon
AMZN
Meta Platforms
META
4
Oracle
ORCL
5
Salesforce
CRM
US Stock MarketDetailed Quotes
ENSC Ensysce Biosciences
- 3.670
- +1.800+96.26%
Close Apr 23 16:00 ET
- 3.030
- -0.640-17.44%
Pre 06:06 ET
6.04MMarket Cap-0.62P/E (TTM)
4.850High3.260Low92.05MVolume4.230Open1.870Pre Close376.23MTurnover8102.82%Turnover RatioLossP/E (Static)1.64MShares14.67052wk High1.63P/B4.17MFloat Cap1.62052wk Low--Dividend TTM1.14MShs Float86364.000Historical High--Div YieldTTM85.03%Amplitude1.620Historical Low4.087Avg Price1Lot Size
Ensysce Biosciences Key Stats
EPS
According to the latest financial report of Ensysce Biosciences, the latest earnings per share (TTM) for the company is -2.90. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Ensysce Biosciences's free cash flow? The latest report shows it as -764.09K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Ensysce Biosciences shows that the company's current ratio is 2.42, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Ensysce Biosciences, the quick ratio is 1.64, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Ensysce Biosciences? The latest ROE figure is -67.15%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Ensysce Biosciences, the total asset return on investment (ROA) is -47.58%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Ensysce Biosciences's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Ensysce Biosciences, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀